Clover Health Investments, Corp. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -1.64%

Clover Health Investments, Corp. EBIT Margin is -1.64% for the Trailing 12 Months (TTM) ending March 31, 2025, a -84.34% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Clover Health Investments, Corp. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -10.47%, a -10.16% change year over year.
  • Clover Health Investments, Corp. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -11.66%, a -59.15% change year over year.
  • Clover Health Investments, Corp. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -28.53%.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin